HspE7 (SGN-00101): Completed Phase I study

StressGen Biotechnologies Corp. (TSE:SSB), Victoria, B.C. Product: HspE7 ( SGN-00101) Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Fusion protein of hea...